CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,563,798
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,563,798. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-08 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −400 | $75.16 | $30K | 735,686 |
| 2026-01-08 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −11,565 | $73.65 | $852K | 4,546,882 |
| 2026-01-08 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −8,135 | $74.38 | $605K | 4,538,747 |
| 2026-01-08 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −300 | $75.20 | $23K | 4,538,447 |
| 2025-12-15 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −28,311 | $74.60 | $2.1M | 230,476 |
| 2025-12-15 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −1,700 | $75.24 | $128K | 228,776 |
| 2025-12-12 | Kumar Neil Chief Executive Officer | Option exercise 10b5-1 | +60,975 | 289,751 | ||
| 2025-12-12 | Kumar Neil Chief Executive Officer | Shares withheld for taxes 10b5-1 | −30,964 | $75.15 | $2.3M | 258,787 |
| 2025-12-12 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units 10b5-1 | −60,975 | 60,976 | ||
| 2025-12-12 | Trimarchi Thomas President and CFO | Shares withheld for taxes | −13,826 | $75.15 | $1.0M | 369,004 |
| 2025-12-12 | Apuli Maricel Chief Accounting Officer | Shares withheld for taxes | −2,003 | $75.15 | $151K | 128,294 |
| 2025-12-08 | Apuli Maricel Chief Accounting Officer | Sale 10b5-1 | −2,000 | $74.26 | $149K | 130,297 |
| 2025-12-05 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −12,517 | $73.05 | $914K | 763,169 |
| 2025-12-05 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −7,483 | $73.76 | $552K | 755,686 |
| 2025-12-05 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −12,288 | $73.04 | $898K | 4,566,159 |
| 2025-12-05 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −7,712 | $73.75 | $569K | 4,558,447 |
| 2025-12-04 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −2,100 | $73.16 | $154K | 793,586 |
| 2025-12-04 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −12,192 | $74.42 | $907K | 781,394 |
| 2025-12-04 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −5,708 | $74.80 | $427K | 775,686 |
| 2025-12-04 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −2,100 | $73.16 | $154K | 4,596,347 |
Page 11 of 19 · 379 trades